Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Special Education
      • Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • DSM-5’s First Pages and ICD-10’s Billing Codes
  • Medical & Educational Downloads
  • Contact Us
Select Page

Prevalence and Risk Factors of Dopamine Agonists Induced Impulse Control Disorders in Patients With Prolactinoma

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Int J Psychiatry Med. 2025 Oct 30:912174251392426. doi: 10.1177/00912174251392426. Online ahead of print. ABSTRACT ObjectiveThis study sought to determine the frequency and factors influencing Impulsive Control Disorders (ICDs) in prolactinoma patients undergoing...

A randomized controlled trial of a lifestyle intervention on wellbeing in patients with systemic lupus erythematosus: Results from “Living well with lupus”

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Lupus. 2025 Oct 30:9612033251394423. doi: 10.1177/09612033251394423. Online ahead of print. ABSTRACT BackgroundPatients with systemic lupus erythematosus (SLE) experience impaired wellbeing and elevated cardiovascular risk. Lifestyle interventions targeting exercise...

Independent versus joint effects of polygenic or family-based schizophrenia risk in diverse ancestry youth in the ABCD study

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Psychol Med. 2025 Oct 30;55:e327. doi: 10.1017/S0033291725102304. ABSTRACT BACKGROUND: Subtle behavioral and cognitive symptoms precede schizophrenia (SCZ) and appear in individuals with elevated risk based on polygenic risk scores (SCZ-PRS) and family history of...

Systematic review and meta-analysis of the effectiveness of ECT in reducing suicidal ideation, self-harm, suicide, and mortality

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Psychol Med. 2025 Oct 30;55:e328. doi: 10.1017/S0033291725102183. ABSTRACT Suicide and self-harm in people with depression are major public health concerns; electroconvulsive therapy (ECT) is a treatment recommended in UK clinical guidelines for severe mood disorders....

Transdermal drug delivery systems for psychological disorders

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Pharm Dev Technol. 2025 Oct 30:1-50. doi: 10.1080/10837450.2025.2576778. Online ahead of print. ABSTRACT The rapid growth in the number of patients with psychological disorders puts immense pressure on the economy, society, and healthcare systems. Various classes of...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments